Complement and cellular cytotoxicity in antibody therapy of cancer

Overview of attention for article published in Expert Opinion on Biological Therapy, May 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent: 5 patents

wikipedia: 3 Wikipedia pages

Readers on

mendeley: 70 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

HUMAN RECOMBINANT MONOCLONAL ANTIBODY AGAINST SARS-COV-2 SPIKE GLYCOPROTEIN

Application WO-2021239949-A1

World Intellectual Property Organisation (WIPO)

02 Dec 2021

ANTIBODY AGAINST CD269 (BCMA)

Application EP-3508503-A1

European Patent Office

10 Jul 2019

Compositions and methods for modulating the activity of complement regulatory proteins on…

Grant US-8753639-B2

United States of America

17 Jun 2014

AN ANTIBODY THAT BINDS CD269 (BCMA) SUITABLE FOR USE IN THE TREATMENT OF PLASMA CELL…

Application WO-2014068079-A1

World Intellectual Property Organisation (WIPO)

08 May 2014

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.